A MESSAGE FROM A CONCERNED COMMUNITY MEMBER — 2019 TERM 4 WEEK 5 NEWSLETTER
Concerned Member State. The regulatory authority in whose territory a clinical trial with the imp is being conducted or is. Web concerned member state a european economic area country in which an application has been submitted for.
A european economic area country in which an application has been submitted for. Then, the applicant seeks approval for the. The regulatory authority in whose territory a clinical trial with the imp is being conducted or is. Web concerned member state a european economic area country in which an application has been submitted for. Web the member state that has already authorised the product is known as the reference member state (rms).
A european economic area country in which an application has been submitted for. Web the member state that has already authorised the product is known as the reference member state (rms). The regulatory authority in whose territory a clinical trial with the imp is being conducted or is. A european economic area country in which an application has been submitted for. Web concerned member state a european economic area country in which an application has been submitted for. Then, the applicant seeks approval for the.
